2011 Annual Meeting | Advanced Topics in Pediatric Neurology II: Genetic Disorders of Brain Development

Date Monday 04/23/12

Time 02:00 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Jonathan W. Mink, MD, PhD, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should be familiar with the advances in the genetics of brain development and the clinical implications of specific mutations leading to abnormal brain development.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Tracks Subspecialty in Focus

Recommended Audience Trainee, Specialist Neurologist

Teaching Styles Didactic

Event Timeline
02:00 PM - 02:50 PM		Recent Advances in Developmental Neurobiology Gary D. Clark, MD
02:50 PM - 03:40 PM		Malformations of Cortical Development Richard J. Leventer, MBBS, FRACP
03:40 PM - 04:00 PM		Break
04:00 PM - 04:50 PM		Focal Cortical Dysplasia John Gaitanis, MD
04:50 PM - 05:40 PM		Dissection of a Human Ciliopathy Locus Identifies a New Cis-Regulatory Module Assembled During Vertebrate Evolution Jeong Ho Lee, MD, PhD
05:40 PM - 06:00 PM		Discussion

Faculty Disclosures
Gary D. Clark, MD	The institution of Dr. Clark has received research support from Greewich pharmaceuticals. The institution of Dr. Clark has received research support from Novartis.
Richard J. Leventer, MBBS, FRACP	No disclosure on file
Jeong Ho Lee, MD, PhD	No disclosure on file
Jonathan W. Mink, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS.
John Gaitanis, MD	No disclosure on file